UiPath Inc. (PATH)
Automate Your Wheel Strategy on PATH
With Tiblio's Option Bot, you can configure your own wheel strategy including PATH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PATH
- Rev/Share 2.5949
- Book/Share 3.3502
- PB 3.8625
- Debt/Equity 0.0422
- CurrentRatio 2.9272
- ROIC -0.0742
- MktCap 6921181426.0
- FreeCF/Share 0.5548
- PFCF 22.6447
- PE -96.7415
- Debt/Assets 0.0272
- DivYield 0
- ROE -0.0396
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 2
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | PATH | BofA Securities | Neutral | Underperform | -- | $10 | March 13, 2025 |
| Initiation | PATH | UBS | -- | Sell | -- | -- | Dec. 12, 2024 |
News
These Analysts Boost Their Forecasts On UiPath After Upbeat Q1 Results
Published: May 30, 2025 by: Benzinga
Sentiment: Positive
UiPath Inc. PATH reported better-than-expected first-quarter financial results and raised its FY26 guidance on Thursday.
Read More
UiPath Inc. (PATH) Q1 2026 Earnings Call Transcript
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Neutral
UiPath Inc. (NYSE:PATH ) Q1 2026 Earnings Conference Call May 29, 2025 5:00 PM ET Company Participants Allise Furlani - VP of IR Daniel Dines - Founder and CEO Ashim Gupta - COO and CFO Conference Call Participants Sheldon McMeans - Barclays Mark Murphy - JPMorgan Bryan Bergin - TD Cowen Terry Tillman - Truist Securities Siti Panigrahi - Mizuho Securities Alex Zukin - Wolfe Research Nick Altmann - Scotia Bank Operator Greetings, and welcome to the UiPath First Quarter 2026 Earnings Conference Call. At this time all participants are in a listen-only mode.
Read More
UiPath (PATH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for UiPath (PATH) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
UiPath (PATH) Beats Q1 Earnings and Revenue Estimates
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
UiPath (PATH) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.13 per share a year ago.
Read More
SPOT vs. PATH: Which Tech Stock Possess Stronger Growth Potential?
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Spotify Technology leverages AI for user growth. UiPath sees a 14% ARR rise, fueled by intelligent automation and retention gains.
Read More
Should You Buy, Sell, or Hold UiPath Stock Before Q1 Earnings?
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
UiPath Inc. PATH is set to report first-quarter fiscal 2026 results on May 29, after the bell.
Read More
Insights Into UiPath (PATH) Q1: Wall Street Projections for Key Metrics
Published: May 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for UiPath (PATH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
Read More
Why UiPath (PATH) Dipped More Than Broader Market Today
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
UiPath (PATH) closed the most recent trading day at $12.44, moving -1.19% from the previous trading session.
Read More
UiPath Shares Down 37% Over a Year: Is a Turnaround in Play?
Published: May 20, 2025 by: Zacks Investment Research
Sentiment: Positive
PATH stock has plunged significantly in a year but has rebounded sharply recently, a recovery or a trap? Here's what investors need to know.
Read More
UiPath Advances Open Agentic Ecosystem through Bi-directional Integrations with Microsoft Copilot Studio
Published: May 19, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)--UiPath announced new capabilities that enable the orchestration of Microsoft Copilot Studio agents alongside UiPath and other third-party agents.
Read More
3 Mid-Cap Stocks Turning Heads in AI, Automation, & Cybersecurity
Published: May 16, 2025 by: MarketBeat
Sentiment: Positive
Investors looking for a balance of risk and reward might turn to mid-cap stocks. Companies in this category may have a similar growth potential as smaller firms with a bit more of the stability typically seen in larger businesses.
Read More
C3.ai vs. UiPath: Which AI Automation Stock Is the Better Buy in 2025?
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
C3.ai, Inc. AI and UiPath Inc. PATH are both high-profile players in the booming AI automation sector. C3.ai specializes in enterprise AI applications, including predictive maintenance and generative AI tools, while UiPath leads in robotic process automation and is evolving toward “agentic AI” solutions.
Read More
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
Read More
Buy 5 Mid-Cap AI Infrastructure Stocks Amid U.S.-China Tariff Deal Hope
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Five mid-cap AI infrastructure stocks to buy are: INOD, FIVN, PATH, IDCC, AVAV.
Read More
Buy 5 Mid-Cap AI Infrastructure Stocks Amid U.S.-China Tariff Deal Hope
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Five mid-cap AI infrastructure stocks to buy are: INOD, FIVN, PATH, IDCC, AVAV.
Read More
The Transformative Rise of Global Robotics: A 2025 Market Analysis
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Robotics is poised for robust growth in 2025. Watch NVDA, ISRG, SERV and PATH for potential market dominance across healthcare, manufacturing and mobility sectors.
Read More
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
Published: May 02, 2025 by: Zacks Investment Research
Sentiment: Positive
UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
UiPath Shares Decline 41% in a Year: Is Now the Time to Buy?
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Negative
With PATH stock recovering after a decline, we assess its current status to decide on the best strategy for the future.
Read More
UiPath's Oversold Status Triggers Cheap Buying Opportunity - Maintain Buy
Published: April 16, 2025 by: Seeking Alpha
Sentiment: Neutral
UiPath's kitchen sink FY2026 guidance has triggered growth concerns after the robust 3Y top/bottom-line performance, with it contributing to the massive selloff thus far. This is worsened by the potentially impacted SaaS demand in both federal and commercial end markets, attributed to the DOGE headwinds and higher recessionary risks. Even so, given the still rich Free Cash Flow generation, robust balance sheet, and the growing ARR, we believe that PATH remains well positioned to outperform from current discounted levels.
Read More
Earnings Estimates Rising for UiPath (PATH): Will It Gain?
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
AppLovin vs. UiPath: Which AI-Driven Tech Stock is a Better Buy?
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a better investment?
Read More
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
Agentic AI Set to Transform Industries in 2025: 4 Stocks to Watch
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Positive
UiPath, Zoom Communication, NVIDIA and Microsoft are leading the charge in transforming industries with agentic AI advancements in 2025.
Read More
UiPath Stock is Down 50% in a Year: A Potential Buying Opportunity?
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
With PATH stock having corrected significantly, we assess its current status to decide on the best strategy for the future.
Read More
Think AI's Prospects Are Overblown? Try This Beaten-Down Growth Stock.
Published: March 26, 2025 by: The Motley Fool
Sentiment: Positive
Is artificial intelligence a bubble? That's the trillion-dollar question.
Read More
The Drop In UiPath Stock Unlocks Long-Term Potential
Published: March 21, 2025 by: Seeking Alpha
Sentiment: Positive
UiPath's ARR is set to hit $1.816B in FY26 (+9% YoY), driven by 98% gross and 110% net retention. Cloud ARR surged past $975M (+50% YoY) as enterprise adoption of AI-driven automation accelerates. Profitability improved with a 32% non-GAAP margin, $328M free cash flow, and $1.7B cash (zero debt).
Read More
Buy 5 Mid and Small Tech Services Stocks With Massive Short-Term Upside
Published: March 21, 2025 by: Zacks Investment Research
Sentiment: Positive
We recommend five small and mid-cap technology services stocks with huge short-term upside price potential. These are: BYRN, RAMP, DAVE, SMGZY, PATH.
Read More
Coronis Health Enhances Healthcare Delivery Systems through UiPath Platform
Published: March 20, 2025 by: Business Wire
Sentiment: Neutral
SYKESVILLE, Md.--(BUSINESS WIRE)--Coronis Health, (Coronis) a leading provider of healthcare revenue cycle management (RCM) solutions, is pleased to announce that it has leveraged the UiPath Platform™ to enhance its healthcare delivery systems. As part of its comprehensive digital transformation strategy, Coronis leverages the UiPath Platform to enhance advanced AI capabilities while ensuring transparency, security, compliance and ethical governance in all automated processes, driving significa.
Read More
4 Leading Robotics Stocks to Watch Amid 2025 Automation Boom
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
AI-powered robotics are set to soar in 2025. Key players like NVDA, ISRG, TSLA and PATH lead transformation across healthcare, manufacturing and mobility sectors.
Read More
Investors Heavily Search UiPath, Inc. (PATH): Here is What You Need to Know
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
About UiPath Inc. (PATH)
- IPO Date 2021-04-21
- Website https://www.uipath.com
- Industry Software - Infrastructure
- CEO Mr. Daniel Solomon Dines
- Employees 3868